http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AR-114798-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4d3f1bfec8ac94cca9554e3c17db5c6d
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-585
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-565
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-55
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J21-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-585
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-565
filingDate 2019-04-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7dbbf880026bd2709b02f022b190c791
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b7fd69900add1ca335f32bbfe48a61d2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4a3041e41c69ef521ecc7a83f74944a5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_65a23dc96e2bcb7dee86db5b64cfc012
publicationDate 2020-10-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber AR-114798-A1
titleOfInvention COMPOUNDS AND THEIR USES TO RELIEVE SYMPTOMS RELATED TO MENOPAUSE
abstract This is related to a hormone replacement therapy, with associated compounds and associated packaging units, for the relief of symptoms related to menopause based on the administration to a female mammal of a component of estetrol daily doses specified, optionally in combination with a progestagenic component. The therapy offers statistically significant efficacy in combination with a favorable side-effect profile compared to currently available methods for the relief of menopausal-related symptoms.
priorityDate 2018-04-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419513598
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID27125

Total number of triples: 28.